Exchange: NASDAQ·Updated 04:44 PM EDT
News
all
press releases
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
More News
Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?
Does Avita Medical Inc. (RCEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.read more...
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)read more...
Benzinga
Avita Medical (RCEL) Upgraded to Buy: Here's Why
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Avita Medical from a "sell" rating to a "strong sell" rating in a report on Saturday...
MarketBeat
AVITA Medical Promotes Interim CEO Cary Vance To CEO
(RTTNews) - AVITA Medical, Inc. (RCEL), a therapeutic acute wound care company, Thursday announced that it has promoted Cary Vance to the role of Chief Executive Officer and President, effective immediately...
Nasdaq News: Markets
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Analysts
Shares of Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat

Advertisement|Remove ads.